Innovations & Patents
Patents
A new patent was granted in 2023, titled “Method for Preventing Progression to Type II Diabetes.” As of 2023, 5 patents have been approved and granted to DDI (Table 6).
Table 6. DDI patents approved till date.
| Docket No. | Year Granted | Title of Invention(s) | Inventors | Co-Inventor(s) |
|---|---|---|---|---|
| 33024.00 | 2020 | Method for preventing progression to metabolic syndrome | Prof. Fahd Al Mulla | Raseeba Nizam, Dr. Ashref Madhoun |
| 33024.01 | 2020 | Use of MicroRNA-103 as Inhibitor for dyslipidemia by repressing ANGPTL8 gene (2020) | Dr. Mohamed Abufarha | Dr. Jehad Abubaker Prof. Fahd Al Mulla Preethi Cherian Irina Alkhairi |
| 33024.02 | 2021 | Use of MicroRNA-181d as Inhibitor for dyslipidemia by repressing ANGPTL3 gene (2021) | Dr. Jehad Abubaker | Dr. Mohamed Abufarha, Prof. Fahd Al Mulla Irina Alkhairi Preethi Cherian |
| 33024.10 | 2021 | Targeting Signaling Crosstalk Between IL-6 and TNF-α for Preventing MMP-9 Induced tumor growth (2021) | Dr. Rasheed Ahmad | Prof. Fahd Al Mulla |
| 33024.08 | 2023 | Method for Preventing Progression to Type II Diabetes | Dr. Amal Ali Hasan |
